The clinical phenotype and evolution of antisynthetase syndrome (ASS) are heterogeneous.
This study was therefore undertaken to identify subgroups of ASS patients with similar …

Thrombosis and platelet dysfunction are potentially important pathophysiologic processes
that have been identified from descriptive studies from patients with pulmonary arterial …

Sarcoidosis is a multisystemic granulomatous disease of unknown etiology that may involve
virtually any organ. Pulmonary involvement predominates, but sarcoidosis can involve …

Objectives: We sought to determine the factors associated with long-term survival in patients
with primary pulmonary hypertension (PPH) treated with continuous epoprostenol infusion …

Background: Pulmonary hypertension (PH) is a rare complication of sarcoidosis, although it
is not uncommon in advanced disease. Methods: A retrospective series of 22 sarcoidosis …

Background Diffuse parenchymal lung disease represents a diverse and challenging group
of pulmonary disorders. A consistent diagnostic approach to diffuse parenchymal lung …

Background Given the phenotypic similarities between rheumatoid arthritis (RA)–associated
interstitial lung disease (ILD)(hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …

We report a large monocentric case series of 82 patients with human immunodeficiency
virus–associated pulmonary arterial hypertension (PAH). No germline mutations of the …

The objective of the study was to estimate the prevalence and incidence of interstitial lung
diseases (ILDs) in Seine-Saint-Denis, a multi-ethnic county of Greater Paris, France …

Question addressed by the study Methotrexate (MTX) is a key anchor drug for rheumatoid
arthritis (RA) management. Fibrotic interstitial lung disease (ILD) is a common complication …